Yayın:
A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBelgin Sever
dc.contributor.authorMasami Otsuka
dc.contributor.authorMikako Fujita
dc.contributor.authorHalil I. Ciftci
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0002-2968-3939
dc.contributor.orcid0000-0001-6705-4052
dc.contributor.orcid0000-0002-9796-7669
dc.date.accessioned2026-05-20T09:35:06Z
dc.date.issued2024-03-25
dc.identifier.doi10.3390/ijms25073659
dc.identifier.endpage3659
dc.identifier.issn1422-0067
dc.identifier.issue7
dc.identifier.openalexW4393159323
dc.identifier.startpage3659
dc.identifier.urihttps://hdl.handle.net/11421/38397
dc.identifier.urihttps://doi.org/10.3390/ijms25073659
dc.identifier.volume25
dc.language.isoen
dc.relation.ispartofInternational Journal of Molecular Sciences
dc.rightsopenAccess
dc.subjectMedicine
dc.subjectHuman immunodeficiency virus (HIV)
dc.subjectCart
dc.subjectDrug
dc.subjectAntiretroviral therapy
dc.subjectVirology
dc.subjectDrug resistance
dc.subjectImmunology
dc.subjectPharmacology
dc.subjectIntensive care medicine
dc.subjectViral load
dc.subjectBiology
dc.titleA Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication
dspace.entity.typePublication

Dosyalar

Koleksiyonlar

Publications